Phase II trial of 6-thioguanine in metastatic breast cancer.
D001772:Blood Cell Count; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D013866:Thioguanine